Quick Answer
Pediatrix Medical Group, Inc. reported Operating Income Loss of $208.81 million for the year ending 2025.
- Pediatrix Medical Group, Inc. showed an increase of +403.9% in Operating Income Loss from 2024 to 2025.
- This data is from Pediatrix Medical Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $104.10 million | Q2 2014: $129.67 million | Q3 2014: $138.14 million | Q4 2014: $141.09 million | Q1 2015: $114.82 million | Q2 2015: $140.96 million | Q3 2015: $151.13 million | Q4 2015: $150.96 million | Q1 2016: $124.23 million | Q2 2016: $147.79 million | Q3 2016: $156.89 million | Q4 2016: $142.78 million | Q1 2017: $106.04 million | Q2 2017: $121.90 million | Q3 2017: $126.43 million | Q4 2017: $125.70 million | Q1 2018: $99.66 million | Q2 2018: $122.39 million | Q3 2018: $104.21 million | Q4 2018: $105.55 million | Q1 2019: $39.99 million | Q2 2019: $43.06 million | Q3 2019: $48.57 million | Q4 2019: $40.14 million | Q1 2020: $10.80 million | Q2 2020: $34.57 million | Q3 2020: $20.46 million | Q4 2020: $32.31 million | Q1 2021: $26.10 million | Q2 2021: $50.02 million | Q3 2021: $58.79 million | Q1 2022: $39.11 million | Q2 2022: $50.16 million | Q3 2022: $47.39 million | Q1 2023: $30.04 million | Q2 2023: $48.50 million | Q3 2023: $40.27 million | Q1 2024: $15.89 million | Q2 2024: -$157.72 million | Q3 2024: $33.83 million | Q1 2025: $32.10 million | Q2 2025: $59.87 million | Q3 2025: $68.05 million.
- Over the full 18 years of available data (2008 to 2025), Pediatrix Medical Group, Inc.'s Operating Income Loss has declined by 13.7%.
- Historical annual values: Fiscal year 2025: $208.81 million | Fiscal year 2024: -$68.71 million | Fiscal year 2023: $7.32 million | Fiscal year 2022: $172.69 million | Fiscal year 2021: $202.92 million | Fiscal year 2020: $98.13 million | Fiscal year 2019: $171.76 million | Fiscal year 2018: $248.39 million | Fiscal year 2017: $454.89 million | Fiscal year 2016: $571.69 million | Fiscal year 2015: $557.87 million | Fiscal year 2014: $513.00 million | Fiscal year 2013: $452.13 million | Fiscal year 2012: $389.52 million | Fiscal year 2011: $355.39 million | Fiscal year 2010: $312.91 million | Fiscal year 2009: $288.93 million | Fiscal year 2008: $242.03 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: